APO Research
Talk to an analyst

APO RESEARCH · REPORT

Intestinal Anti-infective Drugs

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Intestinal Anti-infective Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

27 December 2025191 pages

Choose your research edition.

Industry ResearchIntestinal Anti-infective Drugs Industry Research Report 2026145 pages · $2,950 USDIndustry Growth & TrendsGlobal Intestinal Anti-infective Drugs Industry Growth and Trends Forecast to 2032122 pages · $3,450 USDMarket StructureGlobal Intestinal Anti-infective Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Intestinal Anti-infective Drugs Market Outlook and Growth Opportunities 2026212 pages · $4,250 USDMarket Analysis & ForecastGlobal Intestinal Anti-infective Drugs Market Analysis and Forecast 2026-2032219 pages · $4,950 USD

Market perspective

The global Intestinal Anti-infective Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Intestinal Anti-infective Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Intestinal Anti-infective Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Intestinal Anti-infective Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Intestinal Anti-infective Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Intestinal Anti-infective Drugs include Chongqing Sino Biopharmaceutical Co., Ltd., Chongqing Laimi Pharmaceutical Co., Ltd., Zhejiang Deer Pharmaceutical Co., Ltd., Yunnan Weihe Pharmaceutical Co., Ltd., Yangzhou Sanyao Pharmaceutical Co., Ltd., Tiansheng Pharmaceutical Group Co., Ltd., Teyi Pharmaceutical Group Co., Ltd., Sichuan Ziligong Pharmaceutical Co., Ltd. and Shaanxi Kaiyuan Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Intestinal Anti-infective Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Intestinal Anti-infective Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Intestinal Anti-infective Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Intestinal Anti-infective Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Intestinal Anti-infective Drugs Segment by Company

Chongqing Sino Biopharmaceutical Co., Ltd.

Chongqing Laimi Pharmaceutical Co., Ltd.

Zhejiang Deer Pharmaceutical Co., Ltd.

Yunnan Weihe Pharmaceutical Co., Ltd.

Yangzhou Sanyao Pharmaceutical Co., Ltd.

Tiansheng Pharmaceutical Group Co., Ltd.

Teyi Pharmaceutical Group Co., Ltd.

Sichuan Ziligong Pharmaceutical Co., Ltd.

Shaanxi Kaiyuan Pharmaceutical Co., Ltd.

Shandong Xinhua Pharmaceutical Co., Ltd.

Nanjing Chengong Pharmaceutical Co., Ltd.

Lingyuan Pharmaceutical Co., Ltd.

Jiangxi Pharmaceutical Co., Ltd.

Jiangxi Nanchang Jisheng Pharmaceutical Co., Ltd.

Jilin Jibang Pharmaceutical Co., Ltd.

Jilin Fukang Pharmaceutical Co., Ltd.

Hubei Hendi Pharmaceutical Co., Ltd.

Hainan Hailing Chemical Pharmaceutical Co., Ltd.

Fujian Sanming Tiantai Pharmaceutical Co., Ltd.

Dali Bai Autonomous Prefecture Traditional Chinese Medicine Pharmaceutical Co., Ltd.

Vox Nutrition

Teva Pharmaceuticals

Salix Pharmaceuticals

Otto Chemie Pvt Ltd

Medikonda Nutrients

Botanic Healthcare

AdvaCare Pharma

Intestinal Anti-infective Drugs Segment by Type

Neomycin

Berberine

Rifaximin

Intestinal Anti-infective Drugs Segment by Application

Pharmacy

Hospital

Clinic

Other

Intestinal Anti-infective Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Intestinal Anti-infective Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Intestinal Anti-infective Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Intestinal Anti-infective Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Intestinal Anti-infective Drugs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Intestinal Anti-infective Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Intestinal Anti-infective Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Intestinal Anti-infective Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Intestinal Anti-infective Drugs Industry Trends Table 2. Intestinal Anti-infective Drugs Industry Drivers Table 3. Intestinal Anti-infective Drugs Industry Opportunities and Challenges Table 4. Intestinal Anti-infective Drugs Industry Restraints Table 5. Global Intestinal Anti-infective Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Intestinal Anti-infective Drugs Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Intestinal Anti-infective Drugs Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Intestinal Anti-infective Drugs Sales Market Share by Manufacturers Table 9. Global Intestinal Anti-infective Drugs Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Intestinal Anti-infective Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Intestinal Anti-infective Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Intestinal Anti-infective Drugs Manufacturers, Product Type & Application Table 13. Global Intestinal Anti-infective Drugs Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Intestinal Anti-infective Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Neomycin Table 17. Major Manufacturers of Berberine Table 18. Major Manufacturers of Rifaximin Table 19. Global Intestinal Anti-infective Drugs Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Intestinal Anti-infective Drugs Sales by Type (2021-2026) & (K Units) Table 21. Global Intestinal Anti-infective Drugs Sales by Type (2027-2032) & (K Units) Table 22. Global Intestinal Anti-infective Drugs Sales Market Share by Type (2021-2026) Table 23. Global Intestinal Anti-infective Drugs Sales Market Share by Type (2027-2032) Table 24. Global Intestinal Anti-infective Drugs Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global Intestinal Anti-infective Drugs Revenue by Type (2021-2026) & (K Units) Table 26. Global Intestinal Anti-infective Drugs Revenue by Type (2027-2032) & (K Units) Table 27. Global Intestinal Anti-infective Drugs Revenue Market Share by Type (2021-2026) Table 28. Global Intestinal Anti-infective Drugs Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Pharmacy Table 30. Major Manufacturers of Hospital Table 31. Major Manufacturers of Clinic Table 32. Major Manufacturers of Other Table 33. Global Intestinal Anti-infective Drugs Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Intestinal Anti-infective Drugs Sales by Application (2021-2026) & (K Units) Table 35. Global Intestinal Anti-infective Drugs Sales by Application (2027-2032) & (K Units) Table 36. Global Intestinal Anti-infective Drugs Sales Market Share by Application (2021-2026) Table 37. Global Intestinal Anti-infective Drugs Sales Market Share by Application (2027-2032) Table 38. Global Intestinal Anti-infective Drugs Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 39. Global Intestinal Anti-infective Drugs Revenue by Application (2021-2026) & (K Units) Table 40. Global Intestinal Anti-infective Drugs Revenue by Application (2027-2032) & (K Units) Table 41. Global Intestinal Anti-infective Drugs Revenue Market Share by Application (2021-2026) Table 42. Global Intestinal Anti-infective Drugs Revenue Market Share by Application (2027-2032) Table 43. Global Intestinal Anti-infective Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Intestinal Anti-infective Drugs Sales by Region (2021-2026) & (K Units) Table 45. Global Intestinal Anti-infective Drugs Sales Market Share by Region (2021-2026) Table 46. Global Intestinal Anti-infective Drugs Sales Forecasted by Region (2027-2032) & (K Units) Table 47. Global Intestinal Anti-infective Drugs Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Intestinal Anti-infective Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. North America Intestinal Anti-infective Drugs Sales by Country (2021-2026) & (K Units) Table 50. North America Intestinal Anti-infective Drugs Sales by Country (2027-2032) & (K Units) Table 51. Europe Intestinal Anti-infective Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Europe Intestinal Anti-infective Drugs Sales by Country (2021-2026) & (K Units) Table 53. Europe Intestinal Anti-infective Drugs Sales by Country (2027-2032) & (K Units) Table 54. Asia Pacific Intestinal Anti-infective Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Asia Pacific Intestinal Anti-infective Drugs Sales by Country (2021-2026) & (K Units) Table 56. Asia Pacific Intestinal Anti-infective Drugs Sales by Country (2027-2032) & (K Units) Table 57. South America, Middle East and Africa Intestinal Anti-infective Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. South America, Middle East and Africa Intestinal Anti-infective Drugs Sales by Country (2021-2026) & (K Units) Table 59. South America, Middle East and Africa Intestinal Anti-infective Drugs Sales by Country (2027-2032) & (K Units) Table 60. Global Intestinal Anti-infective Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Intestinal Anti-infective Drugs Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Intestinal Anti-infective Drugs Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Intestinal Anti-infective Drugs Revenue Market Share by Region (2021-2026) Table 64. Global Intestinal Anti-infective Drugs Revenue Market Share by Region (2027-2032) Table 65. Chongqing Sino Biopharmaceutical Co., Ltd. Company Information Table 66. Chongqing Sino Biopharmaceutical Co., Ltd. Business Overview Table 67. Chongqing Sino Biopharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Chongqing Sino Biopharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio Table 69. Chongqing Sino Biopharmaceutical Co., Ltd. Recent Development Table 70. Chongqing Laimi Pharmaceutical Co., Ltd. Company Information Table 71. Chongqing Laimi Pharmaceutical Co., Ltd. Business Overview Table 72. Chongqing Laimi Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Chongqing Laimi Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio Table 74. Chongqing Laimi Pharmaceutical Co., Ltd. Recent Development Table 75. Zhejiang Deer Pharmaceutical Co., Ltd. Company Information Table 76. Zhejiang Deer Pharmaceutical Co., Ltd. Business Overview Table 77. Zhejiang Deer Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Zhejiang Deer Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio Table 79. Zhejiang Deer Pharmaceutical Co., Ltd. Recent Development Table 80. Yunnan Weihe Pharmaceutical Co., Ltd. Company Information Table 81. Yunnan Weihe Pharmaceutical Co., Ltd. Business Overview Table 82. Yunnan Weihe Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Yunnan Weihe Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio Table 84. Yunnan Weihe Pharmaceutical Co., Ltd. Recent Development Table 85. Yangzhou Sanyao Pharmaceutical Co., Ltd. Company Information Table 86. Yangzhou Sanyao Pharmaceutical Co., Ltd. Business Overview Table 87. Yangzhou Sanyao Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Yangzhou Sanyao Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio Table 89. Yangzhou Sanyao Pharmaceutical Co., Ltd. Recent Development Table 90. Tiansheng Pharmaceutical Group Co., Ltd. Company Information Table 91. Tiansheng Pharmaceutical Group Co., Ltd. Business Overview Table 92. Tiansheng Pharmaceutical Group Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Tiansheng Pharmaceutical Group Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio Table 94. Tiansheng Pharmaceutical Group Co., Ltd. Recent Development Table 95. Teyi Pharmaceutical Group Co., Ltd. Company Information Table 96. Teyi Pharmaceutical Group Co., Ltd. Business Overview Table 97. Teyi Pharmaceutical Group Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Teyi Pharmaceutical Group Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio Table 99. Teyi Pharmaceutical Group Co., Ltd. Recent Development Table 100. Sichuan Ziligong Pharmaceutical Co., Ltd. Company Information Table 101. Sichuan Ziligong Pharmaceutical Co., Ltd. Business Overview Table 102. Sichuan Ziligong Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Sichuan Ziligong Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio Table 104. Sichuan Ziligong Pharmaceutical Co., Ltd. Recent Development Table 105. Shaanxi Kaiyuan Pharmaceutical Co., Ltd. Company Information Table 106. Shaanxi Kaiyuan Pharmaceutical Co., Ltd. Business Overview Table 107. Shaanxi Kaiyuan Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Shaanxi Kaiyuan Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio Table 109. Shaanxi Kaiyuan Pharmaceutical Co., Ltd. Recent Development Table 110. Shandong Xinhua Pharmaceutical Co., Ltd. Company Information Table 111. Shandong Xinhua Pharmaceutical Co., Ltd. Business Overview Table 112. Shandong Xinhua Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Shandong Xinhua Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio Table 114. Shandong Xinhua Pharmaceutical Co., Ltd. Recent Development Table 115. Nanjing Chengong Pharmaceutical Co., Ltd. Company Information Table 116. Nanjing Chengong Pharmaceutical Co., Ltd. Business Overview Table 117. Nanjing Chengong Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 118. Nanjing Chengong Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio Table 119. Nanjing Chengong Pharmaceutical Co., Ltd. Recent Development Table 120. Lingyuan Pharmaceutical Co., Ltd. Company Information Table 121. Lingyuan Pharmaceutical Co., Ltd. Business Overview Table 122. Lingyuan Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 123. Lingyuan Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio Table 124. Lingyuan Pharmaceutical Co., Ltd. Recent Development Table 125. Jiangxi Pharmaceutical Co., Ltd. Company Information Table 126. Jiangxi Pharmaceutical Co., Ltd. Business Overview Table 127. Jiangxi Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 128. Jiangxi Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio Table 129. Jiangxi Pharmaceutical Co., Ltd. Recent Development Table 130. Jiangxi Nanchang Jisheng Pharmaceutical Co., Ltd. Company Information Table 131. Jiangxi Nanchang Jisheng Pharmaceutical Co., Ltd. Business Overview Table 132. Jiangxi Nanchang Jisheng Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 133. Jiangxi Nanchang Jisheng Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio Table 134. Jiangxi Nanchang Jisheng Pharmaceutical Co., Ltd. Recent Development Table 135. Jilin Jibang Pharmaceutical Co., Ltd. Company Information Table 136. Jilin Jibang Pharmaceutical Co., Ltd. Business Overview Table 137. Jilin Jibang Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 138. Jilin Jibang Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio Table 139. Jilin Jibang Pharmaceutical Co., Ltd. Recent Development Table 140. Jilin Fukang Pharmaceutical Co., Ltd. Company Information Table 141. Jilin Fukang Pharmaceutical Co., Ltd. Business Overview Table 142. Jilin Fukang Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 143. Jilin Fukang Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio Table 144. Jilin Fukang Pharmaceutical Co., Ltd. Recent Development Table 145. Hubei Hendi Pharmaceutical Co., Ltd. Company Information Table 146. Hubei Hendi Pharmaceutical Co., Ltd. Business Overview Table 147. Hubei Hendi Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 148. Hubei Hendi Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio Table 149. Hubei Hendi Pharmaceutical Co., Ltd. Recent Development Table 150. Hainan Hailing Chemical Pharmaceutical Co., Ltd. Company Information Table 151. Hainan Hailing Chemical Pharmaceutical Co., Ltd. Business Overview Table 152. Hainan Hailing Chemical Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 153. Hainan Hailing Chemical Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio Table 154. Hainan Hailing Chemical Pharmaceutical Co., Ltd. Recent Development Table 155. Fujian Sanming Tiantai Pharmaceutical Co., Ltd. Company Information Table 156. Fujian Sanming Tiantai Pharmaceutical Co., Ltd. Business Overview Table 157. Fujian Sanming Tiantai Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 158. Fujian Sanming Tiantai Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio Table 159. Fujian Sanming Tiantai Pharmaceutical Co., Ltd. Recent Development Table 160. Dali Bai Autonomous Prefecture Traditional Chinese Medicine Pharmaceutical Co., Ltd. Company Information Table 161. Dali Bai Autonomous Prefecture Traditional Chinese Medicine Pharmaceutical Co., Ltd. Business Overview Table 162. Dali Bai Autonomous Prefecture Traditional Chinese Medicine Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 163. Dali Bai Autonomous Prefecture Traditional Chinese Medicine Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio Table 164. Dali Bai Autonomous Prefecture Traditional Chinese Medicine Pharmaceutical Co., Ltd. Recent Development Table 165. Vox Nutrition Company Information Table 166. Vox Nutrition Business Overview Table 167. Vox Nutrition Intestinal Anti-infective Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 168. Vox Nutrition Intestinal Anti-infective Drugs Product Portfolio Table 169. Vox Nutrition Recent Development Table 170. Teva Pharmaceuticals Company Information Table 171. Teva Pharmaceuticals Business Overview Table 172. Teva Pharmaceuticals Intestinal Anti-infective Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 173. Teva Pharmaceuticals Intestinal Anti-infective Drugs Product Portfolio Table 174. Teva Pharmaceuticals Recent Development Table 175. Salix Pharmaceuticals Company Information Table 176. Salix Pharmaceuticals Business Overview Table 177. Salix Pharmaceuticals Intestinal Anti-infective Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 178. Salix Pharmaceuticals Intestinal Anti-infective Drugs Product Portfolio Table 179. Salix Pharmaceuticals Recent Development Table 180. Otto Chemie Pvt Ltd Company Information Table 181. Otto Chemie Pvt Ltd Business Overview Table 182. Otto Chemie Pvt Ltd Intestinal Anti-infective Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 183. Otto Chemie Pvt Ltd Intestinal Anti-infective Drugs Product Portfolio Table 184. Otto Chemie Pvt Ltd Recent Development Table 185. Medikonda Nutrients Company Information Table 186. Medikonda Nutrients Business Overview Table 187. Medikonda Nutrients Intestinal Anti-infective Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 188. Medikonda Nutrients Intestinal Anti-infective Drugs Product Portfolio Table 189. Medikonda Nutrients Recent Development Table 190. Botanic Healthcare Company Information Table 191. Botanic Healthcare Business Overview Table 192. Botanic Healthcare Intestinal Anti-infective Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 193. Botanic Healthcare Intestinal Anti-infective Drugs Product Portfolio Table 194. Botanic Healthcare Recent Development Table 195. AdvaCare Pharma Company Information Table 196. AdvaCare Pharma Business Overview Table 197. AdvaCare Pharma Intestinal Anti-infective Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 198. AdvaCare Pharma Intestinal Anti-infective Drugs Product Portfolio Table 199. AdvaCare Pharma Recent Development Table 200. Key Raw Materials Table 201. Raw Materials Key Suppliers Table 202. Intestinal Anti-infective Drugs Distributors List Table 203. Intestinal Anti-infective Drugs Customers List Table 204. Research Programs/Design for This Report Table 205. Authors List of This Report Table 206. Secondary Sources Table 207. Primary Sources List of Figures Figure 1. Intestinal Anti-infective Drugs Product Image Figure 2. Global Intestinal Anti-infective Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Intestinal Anti-infective Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Intestinal Anti-infective Drugs Sales (2021-2032) & (K Units) Figure 5. Global Intestinal Anti-infective Drugs Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Intestinal Anti-infective Drugs Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Neomycin Image Figure 9. Berberine Image Figure 10. Rifaximin Image Figure 11. Global Intestinal Anti-infective Drugs Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Intestinal Anti-infective Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Intestinal Anti-infective Drugs Sales Market Share by Type (2021-2032) Figure 14. Global Intestinal Anti-infective Drugs Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Intestinal Anti-infective Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Intestinal Anti-infective Drugs Revenue Market Share by Type (2021-2032) Figure 17. Pharmacy Image Figure 18. Hospital Image Figure 19. Clinic Image Figure 20. Other Image Figure 21. Global Intestinal Anti-infective Drugs Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Intestinal Anti-infective Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Intestinal Anti-infective Drugs Sales Market Share by Application (2021-2032) Figure 24. Global Intestinal Anti-infective Drugs Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Intestinal Anti-infective Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Intestinal Anti-infective Drugs Revenue Market Share by Application (2021-2032) Figure 27. North America Intestinal Anti-infective Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 28. North America Intestinal Anti-infective Drugs Sales Market Share by Country (2021-2032) Figure 29. U.S. Intestinal Anti-infective Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Canada Intestinal Anti-infective Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Mexico Intestinal Anti-infective Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Intestinal Anti-infective Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Intestinal Anti-infective Drugs Sales Market Share by Country (2021-2032) Figure 34. Germany Intestinal Anti-infective Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 35. France Intestinal Anti-infective Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 36. U.K. Intestinal Anti-infective Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Italy Intestinal Anti-infective Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Netherlands Intestinal Anti-infective Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Intestinal Anti-infective Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Intestinal Anti-infective Drugs Sales Market Share by Country (2021-2032) Figure 41. China Intestinal Anti-infective Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Japan Intestinal Anti-infective Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 43. South Korea Intestinal Anti-infective Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Southeast Asia Intestinal Anti-infective Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 45. India Intestinal Anti-infective Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Australia Intestinal Anti-infective Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Intestinal Anti-infective Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Intestinal Anti-infective Drugs Sales Market Share by Country (2021-2032) Figure 49. Brazil Intestinal Anti-infective Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South Africa Intestinal Anti-infective Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Saudi Arabia Intestinal Anti-infective Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Turkey Intestinal Anti-infective Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Argentina Intestinal Anti-infective Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 54. UAE Intestinal Anti-infective Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Egypt Intestinal Anti-infective Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Chile Intestinal Anti-infective Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Global Intestinal Anti-infective Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Intestinal Anti-infective Drugs Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Intestinal Anti-infective Drugs Revenue (2021-2032) & (US$ Million) Figure 60. North America Intestinal Anti-infective Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Intestinal Anti-infective Drugs Revenue (2021-2032) & (US$ Million) Figure 62. Europe Intestinal Anti-infective Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Intestinal Anti-infective Drugs Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Intestinal Anti-infective Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Intestinal Anti-infective Drugs Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Intestinal Anti-infective Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Intestinal Anti-infective Drugs Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Intestinal Anti-infective Drugs Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Neomycin
  • Berberine
  • Rifaximin
Applications
  • Pharmacy
  • Hospital
  • Clinic
  • Other
Companies covered
  • Chongqing Sino Biopharmaceutical Co., Ltd.
  • Chongqing Laimi Pharmaceutical Co., Ltd.
  • Zhejiang Deer Pharmaceutical Co., Ltd.
  • Yunnan Weihe Pharmaceutical Co., Ltd.
  • Yangzhou Sanyao Pharmaceutical Co., Ltd.
  • Tiansheng Pharmaceutical Group Co., Ltd.
  • Teyi Pharmaceutical Group Co., Ltd.
  • Sichuan Ziligong Pharmaceutical Co., Ltd.
  • Shaanxi Kaiyuan Pharmaceutical Co., Ltd.
  • Shandong Xinhua Pharmaceutical Co., Ltd.
  • Nanjing Chengong Pharmaceutical Co., Ltd.
  • Lingyuan Pharmaceutical Co., Ltd.
  • Jiangxi Pharmaceutical Co., Ltd.
  • Jiangxi Nanchang Jisheng Pharmaceutical Co., Ltd.
  • Jilin Jibang Pharmaceutical Co., Ltd.
  • Jilin Fukang Pharmaceutical Co., Ltd.
  • Hubei Hendi Pharmaceutical Co., Ltd.
  • Hainan Hailing Chemical Pharmaceutical Co., Ltd.
  • Fujian Sanming Tiantai Pharmaceutical Co., Ltd.
  • Dali Bai Autonomous Prefecture Traditional Chinese Medicine Pharmaceutical Co., Ltd.
  • Vox Nutrition
  • Teva Pharmaceuticals
  • Salix Pharmaceuticals
  • Otto Chemie Pvt Ltd
  • Medikonda Nutrients
  • Botanic Healthcare
  • AdvaCare Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Intestinal Anti-infective Drugs Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Intestinal Anti-infective Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Intestinal Anti-infective Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Intestinal Anti-infective Drugs Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Intestinal Anti-infective Drugs Market Dynamics
  1. 2.1 Intestinal Anti-infective Drugs Industry Trends
  2. 2.2 Intestinal Anti-infective Drugs Industry Drivers
  3. 2.3 Intestinal Anti-infective Drugs Industry Opportunities and Challenges
  4. 2.4 Intestinal Anti-infective Drugs Industry Restraints
3 Intestinal Anti-infective Drugs Market by Manufacturers
  1. 3.1 Global Intestinal Anti-infective Drugs Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Intestinal Anti-infective Drugs Sales by Manufacturers (2021-2026)
  3. 3.3 Global Intestinal Anti-infective Drugs Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Intestinal Anti-infective Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Intestinal Anti-infective Drugs Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Intestinal Anti-infective Drugs Manufacturers, Product Type & Application
  7. 3.7 Global Intestinal Anti-infective Drugs Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Intestinal Anti-infective Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Intestinal Anti-infective Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Intestinal Anti-infective Drugs Tier 1, Tier 2, and Tier 3
4 Intestinal Anti-infective Drugs Market by Type
  1. 4.1 Intestinal Anti-infective Drugs Type Introduction
  2. 4.1.1 Neomycin
  3. 4.1.2 Berberine
  4. 4.1.3 Rifaximin
  5. 4.2 Global Intestinal Anti-infective Drugs Sales by Type
  6. 4.2.1 Global Intestinal Anti-infective Drugs Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Intestinal Anti-infective Drugs Sales by Type (2021-2032)
  8. 4.2.3 Global Intestinal Anti-infective Drugs Sales Market Share by Type (2021-2032)
  9. 4.3 Global Intestinal Anti-infective Drugs Revenue by Type
  10. 4.3.1 Global Intestinal Anti-infective Drugs Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Intestinal Anti-infective Drugs Revenue by Type (2021-2032)
  12. 4.3.3 Global Intestinal Anti-infective Drugs Revenue Market Share by Type (2021-2032)
5 Intestinal Anti-infective Drugs Market by Application
  1. 5.1 Intestinal Anti-infective Drugs Application Introduction
  2. 5.1.1 Pharmacy
  3. 5.1.2 Hospital
  4. 5.1.3 Clinic
  5. 5.1.4 Other
  6. 5.2 Global Intestinal Anti-infective Drugs Sales by Application
  7. 5.2.1 Global Intestinal Anti-infective Drugs Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Intestinal Anti-infective Drugs Sales by Application (2021-2032)
  9. 5.2.3 Global Intestinal Anti-infective Drugs Sales Market Share by Application (2021-2032)
  10. 5.3 Global Intestinal Anti-infective Drugs Revenue by Application
  11. 5.3.1 Global Intestinal Anti-infective Drugs Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Intestinal Anti-infective Drugs Revenue by Application (2021-2032)
  13. 5.3.3 Global Intestinal Anti-infective Drugs Revenue Market Share by Application (2021-2032)
6 Global Intestinal Anti-infective Drugs Sales by Region
  1. 6.1 Global Intestinal Anti-infective Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Intestinal Anti-infective Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Intestinal Anti-infective Drugs Sales by Region (2021-2026)
  4. 6.2.2 Global Intestinal Anti-infective Drugs Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Intestinal Anti-infective Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Intestinal Anti-infective Drugs Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Intestinal Anti-infective Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Intestinal Anti-infective Drugs Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Intestinal Anti-infective Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Intestinal Anti-infective Drugs Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Intestinal Anti-infective Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Intestinal Anti-infective Drugs Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Intestinal Anti-infective Drugs Revenue by Region
  1. 7.1 Global Intestinal Anti-infective Drugs Revenue by Region
  2. 7.1.1 Global Intestinal Anti-infective Drugs Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Intestinal Anti-infective Drugs Revenue by Region (2021-2026)
  4. 7.1.3 Global Intestinal Anti-infective Drugs Revenue by Region (2027-2032)
  5. 7.1.4 Global Intestinal Anti-infective Drugs Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Intestinal Anti-infective Drugs Revenue (2021-2032)
  8. 7.2.2 North America Intestinal Anti-infective Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Intestinal Anti-infective Drugs Revenue (2021-2032)
  11. 7.3.2 Europe Intestinal Anti-infective Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Intestinal Anti-infective Drugs Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Intestinal Anti-infective Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Intestinal Anti-infective Drugs Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Intestinal Anti-infective Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Chongqing Sino Biopharmaceutical Co., Ltd.
  2. 8.1.1 Chongqing Sino Biopharmaceutical Co., Ltd. Company Information
  3. 8.1.2 Chongqing Sino Biopharmaceutical Co., Ltd. Business Overview
  4. 8.1.3 Chongqing Sino Biopharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Chongqing Sino Biopharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
  6. 8.1.5 Chongqing Sino Biopharmaceutical Co., Ltd. Recent Developments
  7. 8.2 Chongqing Laimi Pharmaceutical Co., Ltd.
  8. 8.2.1 Chongqing Laimi Pharmaceutical Co., Ltd. Company Information
  9. 8.2.2 Chongqing Laimi Pharmaceutical Co., Ltd. Business Overview
  10. 8.2.3 Chongqing Laimi Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Chongqing Laimi Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
  12. 8.2.5 Chongqing Laimi Pharmaceutical Co., Ltd. Recent Developments
  13. 8.3 Zhejiang Deer Pharmaceutical Co., Ltd.
  14. 8.3.1 Zhejiang Deer Pharmaceutical Co., Ltd. Company Information
  15. 8.3.2 Zhejiang Deer Pharmaceutical Co., Ltd. Business Overview
  16. 8.3.3 Zhejiang Deer Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Zhejiang Deer Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
  18. 8.3.5 Zhejiang Deer Pharmaceutical Co., Ltd. Recent Developments
  19. 8.4 Yunnan Weihe Pharmaceutical Co., Ltd.
  20. 8.4.1 Yunnan Weihe Pharmaceutical Co., Ltd. Company Information
  21. 8.4.2 Yunnan Weihe Pharmaceutical Co., Ltd. Business Overview
  22. 8.4.3 Yunnan Weihe Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Yunnan Weihe Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
  24. 8.4.5 Yunnan Weihe Pharmaceutical Co., Ltd. Recent Developments
  25. 8.5 Yangzhou Sanyao Pharmaceutical Co., Ltd.
  26. 8.5.1 Yangzhou Sanyao Pharmaceutical Co., Ltd. Company Information
  27. 8.5.2 Yangzhou Sanyao Pharmaceutical Co., Ltd. Business Overview
  28. 8.5.3 Yangzhou Sanyao Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Yangzhou Sanyao Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
  30. 8.5.5 Yangzhou Sanyao Pharmaceutical Co., Ltd. Recent Developments
  31. 8.6 Tiansheng Pharmaceutical Group Co., Ltd.
  32. 8.6.1 Tiansheng Pharmaceutical Group Co., Ltd. Company Information
  33. 8.6.2 Tiansheng Pharmaceutical Group Co., Ltd. Business Overview
  34. 8.6.3 Tiansheng Pharmaceutical Group Co., Ltd. Intestinal Anti-infective Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Tiansheng Pharmaceutical Group Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
  36. 8.6.5 Tiansheng Pharmaceutical Group Co., Ltd. Recent Developments
  37. 8.7 Teyi Pharmaceutical Group Co., Ltd.
  38. 8.7.1 Teyi Pharmaceutical Group Co., Ltd. Company Information
  39. 8.7.2 Teyi Pharmaceutical Group Co., Ltd. Business Overview
  40. 8.7.3 Teyi Pharmaceutical Group Co., Ltd. Intestinal Anti-infective Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Teyi Pharmaceutical Group Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
  42. 8.7.5 Teyi Pharmaceutical Group Co., Ltd. Recent Developments
  43. 8.8 Sichuan Ziligong Pharmaceutical Co., Ltd.
  44. 8.8.1 Sichuan Ziligong Pharmaceutical Co., Ltd. Company Information
  45. 8.8.2 Sichuan Ziligong Pharmaceutical Co., Ltd. Business Overview
  46. 8.8.3 Sichuan Ziligong Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Sichuan Ziligong Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
  48. 8.8.5 Sichuan Ziligong Pharmaceutical Co., Ltd. Recent Developments
  49. 8.9 Shaanxi Kaiyuan Pharmaceutical Co., Ltd.
  50. 8.9.1 Shaanxi Kaiyuan Pharmaceutical Co., Ltd. Company Information
  51. 8.9.2 Shaanxi Kaiyuan Pharmaceutical Co., Ltd. Business Overview
  52. 8.9.3 Shaanxi Kaiyuan Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Shaanxi Kaiyuan Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
  54. 8.9.5 Shaanxi Kaiyuan Pharmaceutical Co., Ltd. Recent Developments
  55. 8.10 Shandong Xinhua Pharmaceutical Co., Ltd.
  56. 8.10.1 Shandong Xinhua Pharmaceutical Co., Ltd. Company Information
  57. 8.10.2 Shandong Xinhua Pharmaceutical Co., Ltd. Business Overview
  58. 8.10.3 Shandong Xinhua Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Shandong Xinhua Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
  60. 8.10.5 Shandong Xinhua Pharmaceutical Co., Ltd. Recent Developments
  61. 8.11 Nanjing Chengong Pharmaceutical Co., Ltd.
  62. 8.11.1 Nanjing Chengong Pharmaceutical Co., Ltd. Company Information
  63. 8.11.2 Nanjing Chengong Pharmaceutical Co., Ltd. Business Overview
  64. 8.11.3 Nanjing Chengong Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Nanjing Chengong Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
  66. 8.11.5 Nanjing Chengong Pharmaceutical Co., Ltd. Recent Developments
  67. 8.12 Lingyuan Pharmaceutical Co., Ltd.
  68. 8.12.1 Lingyuan Pharmaceutical Co., Ltd. Company Information
  69. 8.12.2 Lingyuan Pharmaceutical Co., Ltd. Business Overview
  70. 8.12.3 Lingyuan Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Lingyuan Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
  72. 8.12.5 Lingyuan Pharmaceutical Co., Ltd. Recent Developments
  73. 8.13 Jiangxi Pharmaceutical Co., Ltd.
  74. 8.13.1 Jiangxi Pharmaceutical Co., Ltd. Company Information
  75. 8.13.2 Jiangxi Pharmaceutical Co., Ltd. Business Overview
  76. 8.13.3 Jiangxi Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Jiangxi Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
  78. 8.13.5 Jiangxi Pharmaceutical Co., Ltd. Recent Developments
  79. 8.14 Jiangxi Nanchang Jisheng Pharmaceutical Co., Ltd.
  80. 8.14.1 Jiangxi Nanchang Jisheng Pharmaceutical Co., Ltd. Company Information
  81. 8.14.2 Jiangxi Nanchang Jisheng Pharmaceutical Co., Ltd. Business Overview
  82. 8.14.3 Jiangxi Nanchang Jisheng Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Jiangxi Nanchang Jisheng Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
  84. 8.14.5 Jiangxi Nanchang Jisheng Pharmaceutical Co., Ltd. Recent Developments
  85. 8.15 Jilin Jibang Pharmaceutical Co., Ltd.
  86. 8.15.1 Jilin Jibang Pharmaceutical Co., Ltd. Company Information
  87. 8.15.2 Jilin Jibang Pharmaceutical Co., Ltd. Business Overview
  88. 8.15.3 Jilin Jibang Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Jilin Jibang Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
  90. 8.15.5 Jilin Jibang Pharmaceutical Co., Ltd. Recent Developments
  91. 8.16 Jilin Fukang Pharmaceutical Co., Ltd.
  92. 8.16.1 Jilin Fukang Pharmaceutical Co., Ltd. Company Information
  93. 8.16.2 Jilin Fukang Pharmaceutical Co., Ltd. Business Overview
  94. 8.16.3 Jilin Fukang Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Jilin Fukang Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
  96. 8.16.5 Jilin Fukang Pharmaceutical Co., Ltd. Recent Developments
  97. 8.17 Hubei Hendi Pharmaceutical Co., Ltd.
  98. 8.17.1 Hubei Hendi Pharmaceutical Co., Ltd. Company Information
  99. 8.17.2 Hubei Hendi Pharmaceutical Co., Ltd. Business Overview
  100. 8.17.3 Hubei Hendi Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Hubei Hendi Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
  102. 8.17.5 Hubei Hendi Pharmaceutical Co., Ltd. Recent Developments
  103. 8.18 Hainan Hailing Chemical Pharmaceutical Co., Ltd.
  104. 8.18.1 Hainan Hailing Chemical Pharmaceutical Co., Ltd. Company Information
  105. 8.18.2 Hainan Hailing Chemical Pharmaceutical Co., Ltd. Business Overview
  106. 8.18.3 Hainan Hailing Chemical Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Hainan Hailing Chemical Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
  108. 8.18.5 Hainan Hailing Chemical Pharmaceutical Co., Ltd. Recent Developments
  109. 8.19 Fujian Sanming Tiantai Pharmaceutical Co., Ltd.
  110. 8.19.1 Fujian Sanming Tiantai Pharmaceutical Co., Ltd. Company Information
  111. 8.19.2 Fujian Sanming Tiantai Pharmaceutical Co., Ltd. Business Overview
  112. 8.19.3 Fujian Sanming Tiantai Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Fujian Sanming Tiantai Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
  114. 8.19.5 Fujian Sanming Tiantai Pharmaceutical Co., Ltd. Recent Developments
  115. 8.20 Dali Bai Autonomous Prefecture Traditional Chinese Medicine Pharmaceutical Co., Ltd.
  116. 8.20.1 Dali Bai Autonomous Prefecture Traditional Chinese Medicine Pharmaceutical Co., Ltd. Company Information
  117. 8.20.2 Dali Bai Autonomous Prefecture Traditional Chinese Medicine Pharmaceutical Co., Ltd. Business Overview
  118. 8.20.3 Dali Bai Autonomous Prefecture Traditional Chinese Medicine Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Dali Bai Autonomous Prefecture Traditional Chinese Medicine Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
  120. 8.20.5 Dali Bai Autonomous Prefecture Traditional Chinese Medicine Pharmaceutical Co., Ltd. Recent Developments
  121. 8.21 Vox Nutrition
  122. 8.21.1 Vox Nutrition Company Information
  123. 8.21.2 Vox Nutrition Business Overview
  124. 8.21.3 Vox Nutrition Intestinal Anti-infective Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Vox Nutrition Intestinal Anti-infective Drugs Product Portfolio
  126. 8.21.5 Vox Nutrition Recent Developments
  127. 8.22 Teva Pharmaceuticals
  128. 8.22.1 Teva Pharmaceuticals Company Information
  129. 8.22.2 Teva Pharmaceuticals Business Overview
  130. 8.22.3 Teva Pharmaceuticals Intestinal Anti-infective Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Teva Pharmaceuticals Intestinal Anti-infective Drugs Product Portfolio
  132. 8.22.5 Teva Pharmaceuticals Recent Developments
  133. 8.23 Salix Pharmaceuticals
  134. 8.23.1 Salix Pharmaceuticals Company Information
  135. 8.23.2 Salix Pharmaceuticals Business Overview
  136. 8.23.3 Salix Pharmaceuticals Intestinal Anti-infective Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  137. 8.23.4 Salix Pharmaceuticals Intestinal Anti-infective Drugs Product Portfolio
  138. 8.23.5 Salix Pharmaceuticals Recent Developments
  139. 8.24 Otto Chemie Pvt Ltd
  140. 8.24.1 Otto Chemie Pvt Ltd Company Information
  141. 8.24.2 Otto Chemie Pvt Ltd Business Overview
  142. 8.24.3 Otto Chemie Pvt Ltd Intestinal Anti-infective Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  143. 8.24.4 Otto Chemie Pvt Ltd Intestinal Anti-infective Drugs Product Portfolio
  144. 8.24.5 Otto Chemie Pvt Ltd Recent Developments
  145. 8.25 Medikonda Nutrients
  146. 8.25.1 Medikonda Nutrients Company Information
  147. 8.25.2 Medikonda Nutrients Business Overview
  148. 8.25.3 Medikonda Nutrients Intestinal Anti-infective Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  149. 8.25.4 Medikonda Nutrients Intestinal Anti-infective Drugs Product Portfolio
  150. 8.25.5 Medikonda Nutrients Recent Developments
  151. 8.26 Botanic Healthcare
  152. 8.26.1 Botanic Healthcare Company Information
  153. 8.26.2 Botanic Healthcare Business Overview
  154. 8.26.3 Botanic Healthcare Intestinal Anti-infective Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  155. 8.26.4 Botanic Healthcare Intestinal Anti-infective Drugs Product Portfolio
  156. 8.26.5 Botanic Healthcare Recent Developments
  157. 8.27 AdvaCare Pharma
  158. 8.27.1 AdvaCare Pharma Company Information
  159. 8.27.2 AdvaCare Pharma Business Overview
  160. 8.27.3 AdvaCare Pharma Intestinal Anti-infective Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  161. 8.27.4 AdvaCare Pharma Intestinal Anti-infective Drugs Product Portfolio
  162. 8.27.5 AdvaCare Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Intestinal Anti-infective Drugs Value Chain Analysis
  2. 9.1.1 Intestinal Anti-infective Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Intestinal Anti-infective Drugs Production Mode & Process
  6. 9.2 Intestinal Anti-infective Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Intestinal Anti-infective Drugs Distributors
  9. 9.2.3 Intestinal Anti-infective Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst